Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.85
VOLC's Cash to Debt is ranked higher than
56% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 4.48 vs. VOLC: 0.85 )
VOLC' s 10-Year Cash to Debt Range
Min: 0.25   Max: No Debt
Current: 0.85

Equity to Asset 0.36
VOLC's Equity to Asset is ranked lower than
52% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. VOLC: 0.36 )
VOLC' s 10-Year Equity to Asset Range
Min: -0.89   Max: 0.88
Current: 0.36

-0.89
0.88
F-Score: 3
Z-Score: 1.45
M-Score: -2.83
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -7.60
VOLC's Operating margin (%) is ranked higher than
57% of the 371 Companies
in the Global Medical Devices industry.

( Industry Median: 6.50 vs. VOLC: -7.60 )
VOLC' s 10-Year Operating margin (%) Range
Min: -25.38   Max: 7.4
Current: -7.6

-25.38
7.4
Net-margin (%) -8.76
VOLC's Net-margin (%) is ranked higher than
57% of the 371 Companies
in the Global Medical Devices industry.

( Industry Median: 4.82 vs. VOLC: -8.76 )
VOLC' s 10-Year Net-margin (%) Range
Min: -64.36   Max: 11.09
Current: -8.76

-64.36
11.09
ROE (%) -11.51
VOLC's ROE (%) is ranked higher than
57% of the 368 Companies
in the Global Medical Devices industry.

( Industry Median: 5.93 vs. VOLC: -11.51 )
VOLC' s 10-Year ROE (%) Range
Min: -13.48   Max: 11.23
Current: -11.51

-13.48
11.23
ROA (%) -4.15
VOLC's ROA (%) is ranked higher than
60% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 3.43 vs. VOLC: -4.15 )
VOLC' s 10-Year ROA (%) Range
Min: -234.14   Max: 7.67
Current: -4.15

-234.14
7.67
ROC (Joel Greenblatt) (%) -15.00
VOLC's ROC (Joel Greenblatt) (%) is ranked higher than
59% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 13.69 vs. VOLC: -15.00 )
VOLC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -95.28   Max: 16.41
Current: -15

-95.28
16.41
Revenue Growth (%) 9.50
VOLC's Revenue Growth (%) is ranked higher than
82% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. VOLC: 9.50 )
VOLC' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 20.2
Current: 9.5

0
20.2
EBITDA Growth (%) -54.50
VOLC's EBITDA Growth (%) is ranked lower than
51% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: -3.60 vs. VOLC: -54.50 )
VOLC' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: -7.3
Current: -54.5

» VOLC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

VOLC Guru Trades in Q3 2013

Mariko Gordon 2,592,784 sh (+6.94%)
Paul Tudor Jones Sold Out
Manning & Napier Advisors, Inc 4,804,985 sh (-5.57%)
Steven Cohen 393,400 sh (-49.73%)
Jim Simons 40,500 sh (-96.1%)
» More
Q4 2013

VOLC Guru Trades in Q4 2013

Steven Cohen 194,900 sh (unchged)
Jim Simons Sold Out
Steven Cohen Sold Out
Manning & Napier Advisors, Inc 4,663,127 sh (-2.95%)
Mariko Gordon 390,163 sh (-84.95%)
» More
Q1 2014

VOLC Guru Trades in Q1 2014

Steven Cohen 33,418 sh (New)
Mariko Gordon Sold Out
Manning & Napier Advisors, Inc 3,958,382 sh (-15.11%)
» More
Q2 2014

VOLC Guru Trades in Q2 2014

Manning & Napier Advisors, Inc 4,733,937 sh (+19.59%)
» More
» Details

Insider Trades

Latest Guru Trades with VOLC

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mariko Gordon 2014-03-31 Sold Out 0.35%$19.33 - $23.22 $ 16.1-25%0
Mariko Gordon 2013-12-31 Reduce -84.95%2.38%$18.95 - $24.36 $ 16.1-27%390163
Mariko Gordon 2013-09-30 Add 6.94%0.18%$18.04 - $23.99 $ 16.1-24%2592784
Mariko Gordon 2013-06-30 New Buy2.1%$16.58 - $22.41 $ 16.1-16%2424563
George Soros 2011-12-31 Sold Out 0.03%$21.76 - $30.57 $ 16.1-34%0
George Soros 2011-09-30 Reduce -35.69%0.02%$26.22 - $33.51 $ 16.1-47%67200
George Soros 2011-06-30 New Buy0.05%$24.51 - $31.81 $ 16.1-43%104500
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.70
VOLC's P/B is ranked higher than
75% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. VOLC: 2.70 )
VOLC' s 10-Year P/B Range
Min: 2.2   Max: 10.49
Current: 2.7

2.2
10.49
P/S 2.20
VOLC's P/S is ranked higher than
77% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 3.28 vs. VOLC: 2.20 )
VOLC' s 10-Year P/S Range
Min: 0.68   Max: 6.89
Current: 2.2

0.68
6.89
EV-to-EBIT -23.72
VOLC's EV-to-EBIT is ranked higher than
62% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 44.62 vs. VOLC: -23.72 )
VOLC' s 10-Year EV-to-EBIT Range
Min: 42.5   Max: 142
Current: -23.72

42.5
142
Current Ratio 6.10
VOLC's Current Ratio is ranked higher than
89% of the 379 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. VOLC: 6.10 )
VOLC' s 10-Year Current Ratio Range
Min: 1.49   Max: 9.25
Current: 6.1

1.49
9.25
Quick Ratio 5.30
VOLC's Quick Ratio is ranked higher than
89% of the 379 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. VOLC: 5.30 )
VOLC' s 10-Year Quick Ratio Range
Min: 1.01   Max: 8.31
Current: 5.3

1.01
8.31

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 4.30
VOLC's Price/Tangible Book is ranked higher than
74% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 6.18 vs. VOLC: 4.30 )
VOLC' s 10-Year Price/Tangible Book Range
Min: 2.62   Max: 7.98
Current: 4.3

2.62
7.98
Price/DCF (Projected) 6.90
VOLC's Price/DCF (Projected) is ranked higher than
82% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. VOLC: 6.90 )
VOLC' s 10-Year Price/DCF (Projected) Range
Min: 4.64   Max: 15.1
Current: 6.9

4.64
15.1
Price/Median PS Value 0.50
VOLC's Price/Median PS Value is ranked higher than
96% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 1.18 vs. VOLC: 0.50 )
VOLC' s 10-Year Price/Median PS Value Range
Min: 0.18   Max: 1.63
Current: 0.5

0.18
1.63
Earnings Yield (Greenblatt) 0.90
VOLC's Earnings Yield (Greenblatt) is ranked lower than
55% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 4.90 vs. VOLC: 0.90 )
VOLC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.7   Max: 2.4
Current: 0.9

0.7
2.4
Forward Rate of Return (Yacktman) -0.80
VOLC's Forward Rate of Return (Yacktman) is ranked higher than
72% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. VOLC: -0.80 )
VOLC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -3   Max: -0.6
Current: -0.8

-3
-0.6

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:VQY.Germany
Volcano Corporation designs, develops, manufactures and commercializes a suite of intravascular ultrasound (IVUS) and functional measurement (FM) products that enhance the diagnosis and treatment of vascular and structural heart disease. The company is also developing ultra-high resolution Optical Coherence Tomography (OCT) systems and catheters, Forward-Looking IVUS or FLIVUS systems and catheters and image-guided therapy products. The company's FM offerings include consoles and single-use pressure and flow guide wires used to measure the pressure and flow characteristics of blood around plaque enabling physicians to gauge the plaque's physiological impact on blood flow and pressure. The company's FM products consist of pressure and flow consoles and single-procedure disposable pressure and flow guide wires. Volcano's FM products consist of pressure and flow consoles and single-procedure disposable pressure and flow guide wires. The company's consoles are mobile, proprietary and high speed electronic systems with different functionalities and sizes designed and manufactured to process the signals received from only its guide wires. Volcano's IVUS products consist of ultrasound consoles, single-procedure disposable phased array and rotational IVUS imaging catheters and additional functionality options such as virtual histology (VH), IVUS tissue characterization and ChromaFlo stent apposition analysis. The company's IVUS consoles are marketed as stand-alone units or customized units that could be integrated into a variety of hospital-based interventional surgical suites called catheterization laboratories. The company's IVUS consoles have been designed to serve as a multi-modality platform for its phased array and rotational IVUS catheters, fractional flow reserve, or FFR, pressure wires and Medtronic's Pioneer reentry device. The s5 family of consoles, which became Volcano's primary console following its full commercial launch in July 2006, is smaller, lighter and less expensive to manufacture, and has enhanced functionality. The company's IVUS products incorporate key features that add valuable clinical functionality addressing a number of the historical limitations of conventional IVUS and it intend to incorporate additional functionality in the future. Volcano's manufacturing facility is located in Rancho Cordova, California, where it produces IVUS consoles, FM consoles, IVUS catheters and FM guide wires. The company's console manufacturing strategy is to use third-party manufacturing partners to produce circuit boards and mechanical sub-assemblies.
» More Articles for VOLC

Headlines

Articles On GuruFocus.com
Who Is Mariko Gordon? A Guru to Follow Aug 30 2013 
Weekly Guru Bargains Highlights: GOLD, GFI, SAPMY, APPL, VOLC May 20 2013 
Weekly Guru Bargains Highlights: VOLC, SAPMY, BVN, NEM, TFM May 13 2013 
Weekly Guru Bargains Highlights: GOLD, NEM, ABX, VOLC, GFI May 06 2013 
Weekly 3-Year Low Highlights: PACT, ATI, VLY, VOLC Apr 28 2013 
Weekly Guru Bargains Highlights: AAPL, AEM, VOLC, ABX, TFM Apr 28 2013 
Volcano Corp. (VOLC) President & CEO R Scott Huennekens sells 37,500 Shares Mar 08 2011 
Volcano Corp. (VOLC) CFO John T Dahldorf sells 1,724 Shares Mar 01 2011 
Volcano Corp. (VOLC) President & CEO R Scott Huennekens sells 5,851 Shares Mar 01 2011 
Volcano Corp. (VOLC) President & CEO R Scott Huennekens sells 43,315 Shares Feb 08 2011 


More From Other Websites
Abbott Asset Sale Gives Ammunition for Perrigo: Real M&A Jul 16 2014
Volcano Corp. Poised on Strong IVUS Portfolio Jul 11 2014
VOLCANO CORP Files SEC form 8-K, Change in Directors or Principal Officers Jun 26 2014
Volcano seen as a potential medical device target, says dealReporter Jun 25 2014
Volcano acquisition 'really smart,' says Barrington Jun 20 2014
VOLCANO CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial... Jun 17 2014
Volcano Corp. Is Likely To Be Acquired Soon - Here Is Why Jun 12 2014
Swing Trade Ideas for Thursday, June 12: Pandora, Volcano, More Jun 12 2014
VOLCANO CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Jun 05 2014
VOLCANO CORPORATION iFR Update Call scheduled for 4:30 pm ET today Jun 05 2014
Volcano Corporation Schedules Conference Call, Webcast To Discuss iFR® Technology Market... Jun 03 2014
Volcano Corporation Presentation At Goldman Sachs Healthcare Conference To Be Webcast Jun 02 2014
VOLCANO CORP Files SEC form 8-K, Change in Directors or Principal Officers Jun 02 2014
Volcano to Buy AtheroMed May 28 2014
Volcano has replay of conference call May 28 2014
Volcano acquires AtheroMed May 27 2014
VOLCANO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial... May 27 2014
Volcano Corporation To Hold Conference Call/Webcast Today To Discuss AtheroMed Transaction May 27 2014
Volcano Corporation Announces Agreement To Acquire AtheroMed May 27 2014
Traders look for Volcano to erupt May 27 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide